Verónica Calvo

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice”.

Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice

Journal of Clinical Investigation(2024)10.1172/jci176136

N/A

0.457DataRank · unranked

20 citations

Fei Huang, Jacob R. Enriquez, Jiayi E. Wang, Jennifer B. Nelson, Titli Nargis +20 more

Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.128058

N/A

0DataRank · unranked

16 citations

David Surguladze, An‐Hu Li, Matthew D. Surman, Srikanth Malibhatla, Madhavarao Bandaru +23 more

A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1427

N/A

0DataRank · unranked

43 citations

Wei Zheng, Anna Adam‐Artigues, Kirk A. Staschke, Xin Huang, Julie F. Cheung +11 more

Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.06.561126

N/A

0DataRank · unranked

1 citations

Fei Huang, Jacob R. Enriquez, Jiayi E. Wang, Jennifer B. Nelson, Titli Nargis +20 more